Report of chronic myeloid leukemia in chronic phase from Omega Hospital and Indo-American Centre, Hyderabad, 2004-2010

Abstract Omega hospital and Indo-American Center from Hyderabad presented a data of 55 patients with chronic myeloid leukemia 87% (48) patients were in chronic phase. 5% (3) patients had primary resistance, while 64% (36) had shown good response to imatinib. At a median follow-up of 36 months 73% (4...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of medical and paediatric oncology 2013-07, Vol.34 (3), p.204-205
Main Authors: Dattatreya, P S, Nirni, S S
Format: Article
Language:English
Subjects:
Care and treatment
Chronic myeloid leukemia
Drug therapy
Original
ORIGINAL ARTICLE
Patient outcomes
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c562t-de7c905674e81bdec66bdb3f3333de14be049bf48e2315162dcb19616b831633
cites
container_end_page 205
container_issue 3
container_start_page 204
container_title Indian journal of medical and paediatric oncology
container_volume 34
creator Dattatreya, P S
Nirni, S S
description Abstract Omega hospital and Indo-American Center from Hyderabad presented a data of 55 patients with chronic myeloid leukemia 87% (48) patients were in chronic phase. 5% (3) patients had primary resistance, while 64% (36) had shown good response to imatinib. At a median follow-up of 36 months 73% (40) of patients were in chronic phase.
doi_str_mv 10.4103/0971-5851.123742
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3902626</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A354971226</galeid><sourcerecordid>A354971226</sourcerecordid><originalsourceid>FETCH-LOGICAL-c562t-de7c905674e81bdec66bdb3f3333de14be049bf48e2315162dcb19616b831633</originalsourceid><addsrcrecordid>eNp1kk1r3DAQhk1padK0956KoFB6iDf68telsCxtNhAIlNyFLI3XSm3JlezA_vvKcbrshlY-SGieeeWZeZPkI8ErTjC7wlVB0qzMyIpQVnD6KjmPV1lKCa1eP52X8FnyLoQHjFlG8vJtckZ5PDBCzpPHnzA4PyLXINV6Z41C_R46ZzTqYPoFvZHI2ENsaGUA1HjXo7sedhJtXRjMKDskrUY3Vrt03YM3Slq0ATt6uETbvQYva6kvEcWYpxQT_D5508guwIfn_SK5__H9frNNb--ubzbr21RlOR1TDYWqcJYXHEpSa1B5XuuaNSwuDYTXgHlVN7wEykgsiWpVkyoneV2yWCC7SL4tssNU96DV_EeyE4M3vfR74aQRpxFrWrFzj4JVmOY0jwJfnwW8-z1BGEVvgoKukxbcFAThVUV4Fjsb0c8v0Ac3eRuri1SRl2VZxJEdqJ3sQBjbuPiumkXFmmU8Dow-Pbv6BxU_HQeinIXGxPuThC9HCS3IbmyD66bROBtOQbyAyrsQPDSHZhAsZk-J2TRiNo1YPBVTPh038ZDw10QRuFqAsTXQw1Hd_5P8A9J50SQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1476888710</pqid></control><display><type>article</type><title>Report of chronic myeloid leukemia in chronic phase from Omega Hospital and Indo-American Centre, Hyderabad, 2004-2010</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Dattatreya, P S ; Nirni, S S</creator><creatorcontrib>Dattatreya, P S ; Nirni, S S</creatorcontrib><description>Abstract Omega hospital and Indo-American Center from Hyderabad presented a data of 55 patients with chronic myeloid leukemia 87% (48) patients were in chronic phase. 5% (3) patients had primary resistance, while 64% (36) had shown good response to imatinib. At a median follow-up of 36 months 73% (40) of patients were in chronic phase.</description><identifier>ISSN: 0971-5851</identifier><identifier>EISSN: 0975-2129</identifier><identifier>DOI: 10.4103/0971-5851.123742</identifier><identifier>PMID: 24516311</identifier><language>eng</language><publisher>A-12, 2nd Floor, Sector 2, Noida-201301 UP, India: Thieme Medical and Scientific Publishers Pvt. Ltd</publisher><subject>Care and treatment ; Chronic myeloid leukemia ; Drug therapy ; Original ; ORIGINAL ARTICLE ; Patient outcomes</subject><ispartof>Indian journal of medical and paediatric oncology, 2013-07, Vol.34 (3), p.204-205</ispartof><rights>Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)</rights><rights>COPYRIGHT 2013 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt Ltd Jul-Sep 2013</rights><rights>Copyright: © Indian Journal of Medical and Paediatric Oncology 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c562t-de7c905674e81bdec66bdb3f3333de14be049bf48e2315162dcb19616b831633</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902626/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1476888710?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,44588,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24516311$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dattatreya, P S</creatorcontrib><creatorcontrib>Nirni, S S</creatorcontrib><title>Report of chronic myeloid leukemia in chronic phase from Omega Hospital and Indo-American Centre, Hyderabad, 2004-2010</title><title>Indian journal of medical and paediatric oncology</title><addtitle>Indian J Med Paediatr Oncol</addtitle><description>Abstract Omega hospital and Indo-American Center from Hyderabad presented a data of 55 patients with chronic myeloid leukemia 87% (48) patients were in chronic phase. 5% (3) patients had primary resistance, while 64% (36) had shown good response to imatinib. At a median follow-up of 36 months 73% (40) of patients were in chronic phase.</description><subject>Care and treatment</subject><subject>Chronic myeloid leukemia</subject><subject>Drug therapy</subject><subject>Original</subject><subject>ORIGINAL ARTICLE</subject><subject>Patient outcomes</subject><issn>0971-5851</issn><issn>0975-2129</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>0U6</sourceid><sourceid>PIMPY</sourceid><recordid>eNp1kk1r3DAQhk1padK0956KoFB6iDf68telsCxtNhAIlNyFLI3XSm3JlezA_vvKcbrshlY-SGieeeWZeZPkI8ErTjC7wlVB0qzMyIpQVnD6KjmPV1lKCa1eP52X8FnyLoQHjFlG8vJtckZ5PDBCzpPHnzA4PyLXINV6Z41C_R46ZzTqYPoFvZHI2ENsaGUA1HjXo7sedhJtXRjMKDskrUY3Vrt03YM3Slq0ATt6uETbvQYva6kvEcWYpxQT_D5508guwIfn_SK5__H9frNNb--ubzbr21RlOR1TDYWqcJYXHEpSa1B5XuuaNSwuDYTXgHlVN7wEykgsiWpVkyoneV2yWCC7SL4tssNU96DV_EeyE4M3vfR74aQRpxFrWrFzj4JVmOY0jwJfnwW8-z1BGEVvgoKukxbcFAThVUV4Fjsb0c8v0Ac3eRuri1SRl2VZxJEdqJ3sQBjbuPiumkXFmmU8Dow-Pbv6BxU_HQeinIXGxPuThC9HCS3IbmyD66bROBtOQbyAyrsQPDSHZhAsZk-J2TRiNo1YPBVTPh038ZDw10QRuFqAsTXQw1Hd_5P8A9J50SQ</recordid><startdate>20130701</startdate><enddate>20130701</enddate><creator>Dattatreya, P S</creator><creator>Nirni, S S</creator><general>Thieme Medical and Scientific Publishers Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt Ltd</general><scope>0U6</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130701</creationdate><title>Report of chronic myeloid leukemia in chronic phase from Omega Hospital and Indo-American Centre, Hyderabad, 2004-2010</title><author>Dattatreya, P S ; Nirni, S S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c562t-de7c905674e81bdec66bdb3f3333de14be049bf48e2315162dcb19616b831633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Care and treatment</topic><topic>Chronic myeloid leukemia</topic><topic>Drug therapy</topic><topic>Original</topic><topic>ORIGINAL ARTICLE</topic><topic>Patient outcomes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dattatreya, P S</creatorcontrib><creatorcontrib>Nirni, S S</creatorcontrib><collection>Thieme Connect Journals Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of medical and paediatric oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dattatreya, P S</au><au>Nirni, S S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Report of chronic myeloid leukemia in chronic phase from Omega Hospital and Indo-American Centre, Hyderabad, 2004-2010</atitle><jtitle>Indian journal of medical and paediatric oncology</jtitle><addtitle>Indian J Med Paediatr Oncol</addtitle><date>2013-07-01</date><risdate>2013</risdate><volume>34</volume><issue>3</issue><spage>204</spage><epage>205</epage><pages>204-205</pages><issn>0971-5851</issn><eissn>0975-2129</eissn><abstract>Abstract Omega hospital and Indo-American Center from Hyderabad presented a data of 55 patients with chronic myeloid leukemia 87% (48) patients were in chronic phase. 5% (3) patients had primary resistance, while 64% (36) had shown good response to imatinib. At a median follow-up of 36 months 73% (40) of patients were in chronic phase.</abstract><cop>A-12, 2nd Floor, Sector 2, Noida-201301 UP, India</cop><pub>Thieme Medical and Scientific Publishers Pvt. Ltd</pub><pmid>24516311</pmid><doi>10.4103/0971-5851.123742</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0971-5851
ispartof Indian journal of medical and paediatric oncology, 2013-07, Vol.34 (3), p.204-205
issn 0971-5851
0975-2129
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3902626
source Publicly Available Content Database; PubMed Central
subjects Care and treatment
Chronic myeloid leukemia
Drug therapy
Original
ORIGINAL ARTICLE
Patient outcomes
title Report of chronic myeloid leukemia in chronic phase from Omega Hospital and Indo-American Centre, Hyderabad, 2004-2010
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A26%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Report%20of%20chronic%20myeloid%20leukemia%20in%20chronic%20phase%20from%20Omega%20Hospital%20and%20Indo-American%20Centre,%20Hyderabad,%202004-2010&rft.jtitle=Indian%20journal%20of%20medical%20and%20paediatric%20oncology&rft.au=Dattatreya,%20P%20S&rft.date=2013-07-01&rft.volume=34&rft.issue=3&rft.spage=204&rft.epage=205&rft.pages=204-205&rft.issn=0971-5851&rft.eissn=0975-2129&rft_id=info:doi/10.4103/0971-5851.123742&rft_dat=%3Cgale_pubme%3EA354971226%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c562t-de7c905674e81bdec66bdb3f3333de14be049bf48e2315162dcb19616b831633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1476888710&rft_id=info:pmid/24516311&rft_galeid=A354971226&rfr_iscdi=true